3. Naglazyme – $365,000 per year
The next drug was created to fight the effects of Maroteaux-Lamy syndrome, which is a rare, inherited condition that results in damage to the body due to the inability to properly process nutrients.
Sugars and proteins remain left behind, gathering in the eyes, skin, teeth, nervous system, respiratory system, liver and many other places in the body, resulting in significant damage.
Naglazyme aids patients by acting as a replacement for the malfunctioning enzymes. The medications are injected intravenously in a four-hour infusion.
The treatment can result in easier walking and stair-climbing, even if it doesn’t cure the disease.
